Wright Medical Group N.V. is a global medical device company specializing in extremities and biologics solutions for the treatment of foot, ankle, hand, and wrist conditions. Its product portfolio encompasses ankle replacement systems, small joint implants, bone graft substitutes, and associated surgical instruments, all designed to support minimally invasive procedures and improve patient outcomes.
The company operates in over 25 countries with direct sales forces in North America and Europe and a network of distributors in Asia-Pacific and Latin America. Wright Medical complements its commercial efforts with surgeon education initiatives, clinical training programs, and collaborative research partnerships intended to advance surgical techniques and foster adoption of its novel technologies.
Founded in 1950 and headquartered in Memphis, Tennessee, Wright Medical has expanded through organic growth and strategic acquisitions, most notably its 2015 merger with Tornier, which broadened its portfolio into knee, shoulder, and hip reconstruction. Over the decades, the company has developed a robust intellectual property portfolio, securing key patents in implant design, biomaterials, and fixation technologies.
Under the leadership of experienced medical device executives and clinical experts, Wright Medical pursued a dynamic R&D strategy that yielded several first-to-market products. Prior to its acquisition by Stryker Corporation in 2020, the company established itself as a leader in extremities care. Today, as part of a larger medical technology organization, the Wright Medical business unit continues to focus on delivering targeted solutions for extremity reconstruction and trauma applications.
AI Generated. May Contain Errors.
Free GCVRZ Stock Alerts